20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alaeddine, LM; Azar, NS; Dia, B; Eid, AA; El Khoury, M; Hamza, M; Harb, F; Mogharbil, N; Noureldein, MH; Sabra, R | 1 |
| Ahluwalia, A; Chen, J; Colas, RA; Corder, R; Dalli, J; Finsterbusch, M; Hamers, AJP; Massimo, G; Thiemermann, C; Zafar, M | 1 |
2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cardiomyopathies
| Article | Year |
|---|---|
Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiomyopathies; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hydroxyeicosatetraenoic Acids; Male; NADPH Oxidase 4; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Streptozocin | 2021 |
Endogenously generated arachidonate-derived ligands for TRPV1 induce cardiac protection in sepsis.
Topics: Animals; Calcitonin Gene-Related Peptide; Cardiomyopathies; Cardiotonic Agents; Endotoxemia; Heart; HEK293 Cells; Humans; Hydroxyeicosatetraenoic Acids; Mice; Mice, Inbred C57BL; Myocardium; TRPV Cation Channels | 2018 |